Home > Qtrly Results > MANKIND PHARMA

MANKIND PHARMA
Quarterly Results Analysis [Dec2024]

MANKIND PHARMA is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
COMMUNITY POLL
for MANKIND PHARMA
Please provide your vote to see the results

MANKIND PHARMA Quarterly Results

Consolidated Dec2024
UnAudited
Sep2024
UnAudited
Jun2024
UnAudited
Mar2024
UnAudited
Dec2023
UnAudited
Sep2023
UnAudited
Jun2023
UnAudited
Mar2023
UnAudited
Revenues ₹3,230 Cr ₹3,077 Cr ₹2,893 Cr ₹2,441 Cr ₹2,607 Cr ₹2,708 Cr ₹2,579 Cr ₹2,053 Cr
Expenses ₹2,400 Cr ₹2,226 Cr ₹2,212 Cr ₹1,850 Cr ₹2,000 Cr ₹2,025 Cr ₹1,924 Cr ₹1,636 Cr
Operating Income ₹830 Cr ₹850 Cr ₹682 Cr ₹591 Cr ₹607 Cr ₹683 Cr ₹655 Cr ₹417 Cr
Other Income ₹77 Cr ₹109 Cr ₹101 Cr ₹92 Cr ₹70 Cr ₹60 Cr ₹59 Cr ₹48 Cr
Interest ₹221 Cr ₹7 Cr ₹11 Cr ₹9 Cr ₹9 Cr ₹9 Cr ₹6 Cr ₹5 Cr
Depreciation ₹192 Cr ₹106 Cr ₹108 Cr ₹105 Cr ₹110 Cr ₹96 Cr ₹87 Cr ₹85 Cr
Profit Before Tax ₹494 Cr ₹847 Cr ₹664 Cr ₹569 Cr ₹558 Cr ₹638 Cr ₹620 Cr ₹375 Cr
Profit After Tax ₹381 Cr ₹656 Cr ₹539 Cr ₹474 Cr ₹455 Cr ₹508 Cr ₹489 Cr ₹291 Cr
EPS ₹9.22 ₹16.31 ₹13.39 ₹11.76 ₹11.33 ₹12.51 ₹12.15 ₹7.13
Industry Peers & Returns1W1M1Y
MANKIND PHARMA -0.7% -13.8% 18.2%
SUN PHARMACEUTICAL INDUSTRIES -4.2% -7.7% 24.1%
CIPLA 3.3% -4.8% 6.5%
DR REDDYS LABORATORIES -2.4% -12.8% 1.1%
ZYDUS LIFESCIENCES -0.3% -2.1% 24.5%
DIVIS LABORATORIES -0.6% -5.6% 57.5%
TORRENT PHARMACEUTICALS 3.4% -1.7% 37.7%
LUPIN -3.2% -12.7% 39.3%
AUROBINDO PHARMA -2.4% -12.5% -0.3%

MANKIND PHARMA Quarterly Revenues

Revenues
Q-o-Q

4.99 %

Y-o-Y

23.90 %

Quarters Revenues % Change
Dec2024 ₹3,230 Cr
4.99
Sep2024 ₹3,077 Cr
6.33
Jun2024 ₹2,893 Cr
18.53
Mar2024 ₹2,441 Cr
-6.36
Dec2023 ₹2,607 Cr
-3.74
Sep2023 ₹2,708 Cr
5.02
Jun2023 ₹2,579 Cr
25.62
Mar2023 ₹2,053 Cr -

MANKIND PHARMA Quarterly Operating Profit

Operating Profit
Q-o-Q

-2.38 %

Y-o-Y

36.82 %

Quarters Operating Profit % Change
Dec2024 ₹830 Cr
-2.38
Sep2024 ₹850 Cr
24.68
Jun2024 ₹682 Cr
15.34
Mar2024 ₹591 Cr
-2.54
Dec2023 ₹607 Cr
-11.16
Sep2023 ₹683 Cr
4.25
Jun2023 ₹655 Cr
57.15
Mar2023 ₹417 Cr -
Operating Margins
Q-o-Q

-7.02 %

Y-o-Y

10.45 %

Quarters Operating Margin% % Change
Dec2024 25.69%
-7.02
Sep2024 27.63%
17.28
Jun2024 23.56%
-2.68
Mar2024 24.21%
4.08
Dec2023 23.26%
-7.74
Sep2023 25.21%
-0.71
Jun2023 25.39%
25.07
Mar2023 20.3% -

MANKIND PHARMA Quarterly Profit After Tax

Profit After Tax(PAT)
Q-o-Q

-41.94 %

Y-o-Y

-16.28 %

Quarters Profit After Tax % Change
Dec2024 ₹381 Cr
-41.94
Sep2024 ₹656 Cr
21.73
Jun2024 ₹539 Cr
13.70
Mar2024 ₹474 Cr
4.17
Dec2023 ₹455 Cr
-10.34
Sep2023 ₹508 Cr
3.73
Jun2023 ₹489 Cr
68.24
Mar2023 ₹291 Cr -
PAT Margins
Q-o-Q

-44.68 %

Y-o-Y

-32.42 %

Quarters PAT Margin(%) % Change
Dec2024 11.8 %
-44.68
Sep2024 21.33 %
14.49
Jun2024 18.63 %
-4.07
Mar2024 19.42 %
11.23
Dec2023 17.46 %
-6.88
Sep2023 18.75 %
-1.21
Jun2023 18.98 %
33.94
Mar2023 14.17 % -

MANKIND PHARMA Quarterly Earnings Per Share (EPS)

EPS
Q-o-Q

-43.47 %

Y-o-Y

-18.62 %

Quarters EPS % Change
Dec2024 ₹9.22
-43.47
Sep2024 ₹16.31
21.81
Jun2024 ₹13.39
13.86
Mar2024 ₹11.76
3.80
Dec2023 ₹11.33
-9.43
Sep2023 ₹12.51
2.96
Jun2023 ₹12.15
70.41
Mar2023 ₹7.13 -

You may also like the below Video Courses